Portfolio Detail Melinta Therapeutics (formerly Rib-X Pharmaceuticals)

Venture Portfolio

Melinta Therapeutics (formerly Rib-X Pharmaceuticals)

CEO:
Mary Szela

Year Established:
2000

About:
Melinta Therapeutics is an antibiotics company engaged in the discovery, development and commercialization of antibiotics to overcome drug-resistant, life-threatening infections. Melinta was formerly known as Rib-X Pharmaceuticals, and changed its name to Melinta Therapeutics on October 7, 2013.

Website:
www.melinta.com

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio